ALTERATIONS OF ADRENOCEPTORS IN THE NASAL-MUCOSA OF ALLERGIC PATIENTS IN COMPARISON WITH NONALLERGIC INDIVIDUALS

被引:16
作者
VANMEGEN, YJB
KLAASSEN, ABM
DEMIRANDA, JFR
VANGINNEKEN, CAM
WENTGES, BTR
机构
[1] CATHOLIC UNIV NIJMEGEN,DEPT OTORHINOLARYNGOL,NIJMEGEN,NETHERLANDS
[2] CATHOLIC UNIV NIJMEGEN,DEPT PHARMACOL,NIJMEGEN,NETHERLANDS
关键词
D O I
10.1016/0091-6749(91)90012-D
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Nasal hyperreactivity in nasal allergy may be due to changes of the characteristics in adrenergic receptors. Radioligand receptor-binding studies with the antagonists, H-3-prazosin (alpha-1-adrenoceptor), H-3-rauwolscine (alpha-adrenoceptor), and I-125-(-)-Cyanopindolol (beta-adrenoceptor) were performed in homogenates of nasal mucosa of allergic and nonallergic (NA) patients to investigate this hypothesis. The heterogeneous NA group was subdivided into control individuals and patients with chronic sinusitis and vasomotor rhinitis. No significant differences in affinities or densities of alpha-1- and alpha-2-adrenoceptors could be demonstrated in allergic patients in comparison with NA and control individuals. The beta-adrenoceptor density was significantly reduced in allergic patients in comparison with that of control individuals. Neither changes in agonist binding or in the effect of Gpp(NH)p on the agonist binding to beta-adrenoceptors could be observed in allergic patients. The subtype selective antagonist, LK203-030, demonstrated the presence of a homogeneous population of beta-2-adrenoceptors in human nasal mucosa of both NA and allergic patients. In vitro, autoradiography demonstrated specific I-125-(-)-Cyanopindolol labeling of the epithelium in NA and allergic patients. In conclusion, no changes in characteristics of alpha-1- or alpha-2-adrenoceptors in the nasal mucosa could be demonstrated in nasal allergy. However, a decreased number of beta-adrenoceptors may reflect a beta-adrenergic abnormality in nasal allergy.
引用
收藏
页码:530 / 540
页数:11
相关论文
共 40 条
[1]   INCREASED PULMONARY ALPHA-ADRENERGIC AND REDUCED BETA-ADRENERGIC RECEPTORS IN EXPERIMENTAL ASTHMA [J].
BARNES, PJ ;
DOLLERY, CT ;
MACDERMOT, J .
NATURE, 1980, 285 (5766) :569-571
[2]   MUSCARINIC RECEPTOR SUBTYPES IN AIRWAYS [J].
BARNES, PJ ;
MINETTE, P ;
MACLAGAN, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (11) :412-416
[3]   SYMPATHOMIMETICS IN NASAL ALLERGY [J].
BENDE, M ;
LAURIN, L .
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 1986, 48 (04) :238-242
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]  
BROOKS C D, 1988, Rhinology (Utrecht), V26, P51
[6]  
CARSTAIRS JR, 1985, AM REV RESPIR DIS, V132, P541
[7]  
CHEUNG AH, 1989, MOL PHARMACOL, V34, P132
[8]   GENETIC INFLUENCES ON AGONIST BINDING TO CARDIAC BETA-RECEPTORS [J].
CHRIST, GJ ;
DUNLAP, CE ;
BLIZARD, DA .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (07) :1281-1286
[9]  
DAVIS B, 1979, AM REV RESPIR DIS, V120, P547
[10]  
DELEAN A, 1982, MOL PHARMACOL, V21, P5